MRP ₹159
(Inclusive of all Taxes)
₹23.9 Cashback (15%)
Extra 15% Off with Bank Offers
Composition :
BRIVARACETAM-50MG
Manufacturer/Marketer :
Sri Sri Pharma
Consume Type :
Oral
Expires on or after :
Return Policy :
Not Returnable
Secure Payment
Trusted by 8 Crore Indians
Genuine Products
Author Details
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Alcohol
Pregnancy
Breast Feeding
Driving
Liver
Kidney
Children
Product Substitutes
Drug-Drug Interactions
BrivaracetamEsketamine
Severe
Severe
Drug-Drug Interactions
Login/Sign Up
BrivaracetamEsketamine
Severe
How does the drug interact with Brivanil-50 Tablet:
Co-administration of Brivanil-50 Tablet with Esketamine may increase side effects such as drowsiness, difficulty concentrating, confusion, and impairment in thinking, judgment, reaction speed, and motor coordination.
How to manage the interaction:
Although there is an interaction, Brivanil-50 Tablet can be taken with Esketamine if prescribed by the doctor. Consult the prescriber if you notice drowsiness, difficulty concentrating, confusion, and impairment in thinking, judgment, reaction speed, and motor coordination. Do not discontinue the medication without consulting a doctor
Co-administration of Brivanil-50 Tablet with Esketamine may increase side effects such as drowsiness, difficulty concentrating, confusion, and impairment in thinking, judgment, reaction speed, and motor coordination.
How to manage the interaction:
Although there is an interaction, Brivanil-50 Tablet can be taken with Esketamine if prescribed by the doctor. Consult the prescriber if you notice drowsiness, difficulty concentrating, confusion, and impairment in thinking, judgment, reaction speed, and motor coordination. Do not discontinue the medication without consulting a doctor
Severe
How does the drug interact with Brivanil-50 Tablet:
Co-administration of Brivanil-50 Tablet with Ketamine may increase side effects such as drowsiness, difficulty concentrating, confusion, and impairment in thinking, judgment, reaction speed, and motor coordination.
How to manage the interaction:
Although there is a possible interaction between Brivanil-50 Tablet and Ketamine, you can take these medicines together if prescribed by a doctor. If you notice any of these signs - feeling dizzy, sleepy, confused, having trouble focusing, feeling too relaxed, or having trouble breathing - make sure to contact adoctor right away. Do not stop using any medications without talking to a doctor.
Co-administration of Brivanil-50 Tablet with Ketamine may increase side effects such as drowsiness, difficulty concentrating, confusion, and impairment in thinking, judgment, reaction speed, and motor coordination.
How to manage the interaction:
Although there is a possible interaction between Brivanil-50 Tablet and Ketamine, you can take these medicines together if prescribed by a doctor. If you notice any of these signs - feeling dizzy, sleepy, confused, having trouble focusing, feeling too relaxed, or having trouble breathing - make sure to contact adoctor right away. Do not stop using any medications without talking to a doctor.
Moderate
How does the drug interact with Brivanil-50 Tablet:
Brimonidine may be absorbed into the bloodstream and occasionally produce central nervous system side effects such as dizziness, drowsiness, and difficulty concentrating. Concomitant use of Brivanil-50 Tablet with brimonidine may increase the risk of these side effects.
How to manage the interaction:
Although there is an interaction Brivanil-50 Tablet can be taken with brimonidine if prescribed by the doctor. Consult the prescriber if you notice dizziness, drowsiness, and difficulty concentrating.
Brimonidine may be absorbed into the bloodstream and occasionally produce central nervous system side effects such as dizziness, drowsiness, and difficulty concentrating. Concomitant use of Brivanil-50 Tablet with brimonidine may increase the risk of these side effects.
How to manage the interaction:
Although there is an interaction Brivanil-50 Tablet can be taken with brimonidine if prescribed by the doctor. Consult the prescriber if you notice dizziness, drowsiness, and difficulty concentrating.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
BRIVARACETAM-50MGSymptoms and signs involving emotional state
Moderate
BRIVARACETAM-50MGOther chronic obstructive pulmonary disease
Moderate
Drug-Diseases Interactions
Login/Sign Up
BRIVARACETAM-50MGSymptoms and signs involving emotional state
Moderate
How does the disease interact with Brivanil-50 Tablet:
Brivanil-50 Tablet which treat epilepsy, have been linked to an elevated risk of suicidal ideas or actions in individuals taking them for any reason. A dosage reduction or therapy termination should be taken into consideration if patients exhibit signs of suicidal ideation or behaviour.
How to manage the interaction:
Anti-epileptic drugs have been associated with an increased risk of suicidal thoughts or behavior. It should be administered with caution in patients with depression or other psychiatric disorders. Consult the doctor if you notice signs and symptoms of depression, any unusual changes in mood or behavior, or the emergence of suicidal thoughts or behavior. If patients have symptoms of suicidal ideation or behavior, a dosage reduction or treatment discontinuation should be considered.
Brivanil-50 Tablet which treat epilepsy, have been linked to an elevated risk of suicidal ideas or actions in individuals taking them for any reason. A dosage reduction or therapy termination should be taken into consideration if patients exhibit signs of suicidal ideation or behaviour.
How to manage the interaction:
Anti-epileptic drugs have been associated with an increased risk of suicidal thoughts or behavior. It should be administered with caution in patients with depression or other psychiatric disorders. Consult the doctor if you notice signs and symptoms of depression, any unusual changes in mood or behavior, or the emergence of suicidal thoughts or behavior. If patients have symptoms of suicidal ideation or behavior, a dosage reduction or treatment discontinuation should be considered.
BRIVARACETAM-50MGOther chronic obstructive pulmonary disease
Moderate
How does the disease interact with Brivanil-50 Tablet:
Patients taking Brivanil-50 Tablet have been documented to experience bronchospasm and angioedema, and a hypersensitive reaction to this medication could put patients at danger. Brivanil-50 Tablet should be used with caution in patients who are prone to bronchospasm and angioedema.
How to manage the interaction:
Bronchospasm (tightening of muscles in the airways) and angioedema (swelling) have been reported in patients taking Brivanil-50 Tablet. Caution is advised when using Brivanil-50 Tablet in patients with bronchospasm and angioedema.
Patients taking Brivanil-50 Tablet have been documented to experience bronchospasm and angioedema, and a hypersensitive reaction to this medication could put patients at danger. Brivanil-50 Tablet should be used with caution in patients who are prone to bronchospasm and angioedema.
How to manage the interaction:
Bronchospasm (tightening of muscles in the airways) and angioedema (swelling) have been reported in patients taking Brivanil-50 Tablet. Caution is advised when using Brivanil-50 Tablet in patients with bronchospasm and angioedema.
BRIVARACETAM-50MGHepatic failure, not elsewhere classified
Moderate
How does the disease interact with Brivanil-50 Tablet:
In the liver, Brivanil-50 Tablet is largely metabolised via hydrolysis. In comparison to matched healthy controls, Brivanil-50 Tablet exposure increased by 50%, 57%, and 59%, respectively, in adult patients with hepatic cirrhosis and Child-Pugh categories A, B, and C. According to the manufacturer's prescription, dosage adjustment is advised for all stages of hepatic impairment due to increases in Brivanil-50 Tablet exposure. When administering this medication to patients with liver illness, caution and close observation are advised.
How to manage the interaction:
Dosage adjustment is recommended for all stages of hepatic impairment. Care and close monitoring is advised when using this medicine in patients with liver disease.
In the liver, Brivanil-50 Tablet is largely metabolised via hydrolysis. In comparison to matched healthy controls, Brivanil-50 Tablet exposure increased by 50%, 57%, and 59%, respectively, in adult patients with hepatic cirrhosis and Child-Pugh categories A, B, and C. According to the manufacturer's prescription, dosage adjustment is advised for all stages of hepatic impairment due to increases in Brivanil-50 Tablet exposure. When administering this medication to patients with liver illness, caution and close observation are advised.
How to manage the interaction:
Dosage adjustment is recommended for all stages of hepatic impairment. Care and close monitoring is advised when using this medicine in patients with liver disease.
BRIVARACETAM-50MGUnspecified kidney failure
Moderate
How does the disease interact with Brivanil-50 Tablet:
Patients with compromised renal function do not require dose modifications. As there are no data in this patient population, Brivanil-50 Tablet is not advised for use in patients with end-stage renal disease receiving dialysis.
How to manage the interaction:
The use of Brivanil-50 Tablet is not recommended in patients with end-stage renal disease undergoing dialysis as there are no data in this patient population.
Patients with compromised renal function do not require dose modifications. As there are no data in this patient population, Brivanil-50 Tablet is not advised for use in patients with end-stage renal disease receiving dialysis.
How to manage the interaction:
The use of Brivanil-50 Tablet is not recommended in patients with end-stage renal disease undergoing dialysis as there are no data in this patient population.
All Substitutes & Brand Comparisons
RX
Brivepsy 50 Tablet 10's
Cipla Ltd
₹154.5
(₹13.91 per unit)
2% CHEAPERRX
Bricet 50 Tablet 10's
Eris Life Sciences Ltd
₹162
(₹14.58 per unit)
1% COSTLIERRX
Brivazen 50 Tablet 10's
Intas Pharmaceuticals Ltd
₹165
(₹14.85 per unit)
3% COSTLIER
Have a query?